X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-05 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $143.29 | -6,000 | 143,768 | -4% | -$859,734 | ||||||
2025-03-05 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $143.40 | -87,272 | 203,354 | -30% | -$12,515,006 | ||||||
2025-03-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $4.16 | -99 | 43,885 | 0% | -$412 | ||||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale+OE | $4.16 | -1,338 | 203,800 | -1% | -$5,566 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale+OE | $4.16 | -2,285 | 138,544 | -2% | -$9,506 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale+OE | $4.16 | -3,251 | 125,631 | -3% | -$13,524 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale+OE | $4.16 | -2,044 | 170,850 | -1% | -$8,503 | |||||
| D | 2025-03-06 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale+OE | $4.16 | -540 | 314,520 | 0% | -$2,246 | |||||
2025-03-05 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $174.13 | -5,370 | 72,495 | -7% | -$935,078 | ||||||
| M | 2025-03-05 | RDNT | Radnet, Inc. | Wesdorp Cornelis | Pres, CEO, Digital Health | S - Sale | $51.63 | -5,000 | 55,995 | -8% | -$258,140 | |||||
2025-03-05 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $255.64 | -500 | 13,454 | -4% | -$127,817 | ||||||
2025-03-04 | VCYT | Veracyte, Inc. | Febbo Phillip G. | Chief Scientific, Med Officer | S - Sale | $33.35 | -8,037 | 82,540 | -9% | -$268,013 | ||||||
2025-03-04 | VCYT | Veracyte, Inc. | Stapley Marc | CEO | S - Sale | $33.34 | -52,697 | 268,035 | -16% | -$1,756,855 | ||||||
2025-03-04 | VCYT | Veracyte, Inc. | McGuire Annie | SVP, GC | S - Sale | $33.69 | -1,142 | 70,308 | -2% | -$38,476 | ||||||
2025-03-05 | FLGT | Fulgent Genetics, Inc. | Kim Paul | CFO, Treasurer | P - Purchase | $15.96 | +100,000 | 348,282 | +40% | +$1,596,470 | ||||||
| D | 2025-03-03 | GH | Guardant Health, Inc. | Joyce Meghan V. | Dir | S - Sale+OE | $42.71 | -100 | 7,714 | -1% | -$4,271 | |||||
2025-03-04 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $175.79 | -716 | 77,865 | -1% | -$125,866 | ||||||
2025-03-04 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $175.79 | -592 | 48,400 | -1% | -$104,068 | ||||||
| D | 2025-02-28 | LH | Labcorp Holdings Inc. | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale+OE | $249.23 | -5,339 | 4,960 | -52% | -$1,330,639 | |||||
2025-02-27 | VCYT | Veracyte, Inc. | Leite John | Chief Commercial Officer-CLIA | S - Sale | $33.84 | -5,746 | 71,420 | -7% | -$194,445 | ||||||
2025-02-26 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $160.50 | -5,700 | 347,353 | -2% | -$914,873 | ||||||
2025-02-27 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $172.61 | -528 | 44,672 | -1% | -$91,138 | ||||||
2025-02-27 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $172.61 | -824 | 73,606 | -1% | -$142,231 | ||||||
2025-02-25 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale | $251.30 | -1,314 | 2,171 | -38% | -$330,208 | ||||||
2025-02-24 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale | $250.40 | -226 | 4,545 | -5% | -$56,590 | ||||||
2025-02-20 | CSTL | Castle Biosciences Inc | Stokes Frank | CFO | S - Sale | $26.70 | -8,046 | 35,319 | -19% | -$214,828 | ||||||
2025-02-20 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $48.33 | -116 | 3,078 | -4% | -$5,606 | ||||||
2025-02-20 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $170.99 | -604 | 45,486 | -1% | -$103,278 | ||||||
2025-02-19 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | S - Sale | $169.71 | -320 | 18,082 | -2% | -$54,307 | ||||||
| M | 2025-02-19 | DGX | Quest Diagnostics Inc | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $170.51 | -1,434 | 74,885 | -2% | -$244,515 | |||||
| D | 2025-02-18 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale+OE | $246.10 | -1,413 | 1,993 | -41% | -$347,739 | |||||
2025-02-13 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $4.28 | -3,610 | 103,112 | -3% | -$15,451 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $4.58 | -101 | 43,984 | 0% | -$463 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $4.58 | -14,075 | 779,459 | -2% | -$64,464 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $4.58 | -5,342 | 158,128 | -3% | -$24,466 | ||||||
2025-02-13 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $4.58 | -5,915 | 106,239 | -5% | -$27,091 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $4.58 | -7,297 | 106,722 | -6% | -$33,420 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $4.58 | -5,915 | 125,884 | -4% | -$27,091 | ||||||
2025-02-12 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $4.58 | -5,915 | 277,410 | -2% | -$27,091 | ||||||
2025-02-11 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $3.97 | -554 | 114,019 | 0% | -$2,199 | ||||||
| D | 2025-02-12 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $14.67 | -424 | 34,000 | -1% | -$6,220 | |||||
| D | 2025-02-12 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $14.67 | -540 | 35,335 | -2% | -$7,922 | |||||
| D | 2025-02-11 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale+OE | $244.62 | -6,121 | 88,182 | -6% | -$1,497,319 | |||||
| D | 2025-02-11 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $0.92 | -3,630 | 17,623 | -17% | -$3,355 | |||||
| D | 2025-02-11 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $0.92 | -16,748 | 156,008 | -10% | -$15,479 | |||||
| D | 2025-02-11 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $0.92 | -17,527 | 128,039 | -12% | -$16,198 | |||||
| D | 2025-02-11 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $0.92 | -83,660 | 701,947 | -11% | -$77,319 | |||||
| D | 2025-02-11 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $0.92 | -24,664 | 246,460 | -9% | -$22,794 | |||||
| D | 2025-02-10 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $14.80 | -578 | 34,331 | -2% | -$8,554 | |||||
| D | 2025-02-10 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $14.80 | -773 | 33,214 | -2% | -$11,440 | |||||
2025-02-06 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $177.77 | -1,632 | 149,768 | -1% | -$290,121 | ||||||
2025-02-06 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $177.77 | -663 | 156,044 | 0% | -$117,862 | ||||||
2025-02-05 | DGX | Quest Diagnostics Inc | Gregg Vicky B | Dir | S - Sale | $164.57 | -1,250 | 16,867 | -7% | -$205,710 | ||||||
2025-02-05 | DGX | Quest Diagnostics Inc | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $164.30 | -403 | 4,624 | -8% | -$66,214 | ||||||
2025-02-05 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $28.17 | -7,867 | 13,291 | -37% | -$221,637 | ||||||
2025-02-03 | VCYT | Veracyte, Inc. | Chambers Rebecca | CFO | S - Sale | $43.85 | -527 | 113,510 | 0% | -$23,109 | ||||||
2025-02-04 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $23.30 | -3,512 | 104,677 | -3% | -$81,829 | ||||||
| M | 2025-01-31 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $176.85 | -43,902 | 70,629 | -38% | -$7,763,862 | |||||
| M | 2025-01-29 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $169.12 | -6,221 | 101,811 | -6% | -$1,052,112 | |||||
| M | 2025-01-29 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $167.31 | -1,217 | 349,504 | 0% | -$203,613 | |||||
2025-01-29 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $165.87 | -6,003 | 2,467,177 | 0% | -$995,716 | ||||||
2025-01-29 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $165.87 | -4,773 | 213,020 | -2% | -$791,694 | ||||||
2025-01-29 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $165.87 | -5,201 | 135,483 | -4% | -$862,688 | ||||||
2025-01-29 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $165.87 | -4,030 | 143,200 | -3% | -$668,454 | ||||||
2025-01-29 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $165.87 | -13,685 | 253,944 | -5% | -$2,269,928 | ||||||
2025-01-28 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $5.79 | -708 | 166,390 | 0% | -$4,099 | ||||||
2025-01-28 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $5.79 | -519 | 123,367 | 0% | -$3,005 | ||||||
2025-01-27 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $161.87 | -1,442 | 108,032 | -1% | -$233,417 | ||||||
| DM | 2025-01-23 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $171.67 | -1,441 | 109,474 | -1% | -$247,378 | |||||
2025-01-22 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $164.97 | -24,861 | 140,684 | -15% | -$4,101,226 | ||||||
2025-01-22 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $164.97 | -21,228 | 147,230 | -13% | -$3,501,905 | ||||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $165.00 | -971 | 351,309 | 0% | -$160,214 | |||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $164.97 | -22,039 | 217,793 | -9% | -$3,635,685 | |||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $164.97 | -78,553 | 267,629 | -23% | -$12,958,585 | |||||
| D | 2025-01-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $164.97 | -25,931 | 109,665 | -19% | -$4,277,735 | |||||
2025-01-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $37.58 | -116 | 2,944 | -4% | -$4,359 | ||||||
2025-01-13 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $28.03 | -2,565 | 381,894 | -1% | -$71,903 | ||||||
| M | 2025-01-10 | SERA | Sera Prognostics, Inc. | Phillips Joshua | Dir | S - Sale | $6.74 | -34,211 | 0 | -100% | -$230,469 | |||||
| M | 2025-01-10 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $6.80 | -29,591 | 112,154 | -21% | -$201,133 | |||||
| M | 2025-01-10 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $7.27 | -16,473 | 114,573 | -13% | -$119,678 | |||||
2025-01-10 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $7.42 | -13,419 | 163,470 | -8% | -$99,565 | ||||||
2025-01-10 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $8.06 | -2,431 | 283,325 | -1% | -$19,594 | ||||||
| D | 2025-01-13 | FTRE | Fortrea Holdings Inc. | Pike Thomas | CEO | S - Sale+OE | $18.04 | -11,268 | 159,868 | -7% | -$203,275 | |||||
2025-01-08 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $175.30 | -6,223 | 199,804 | -3% | -$1,090,901 | ||||||
2025-01-06 | CSTL | Castle Biosciences Inc | Bradbury Daniel | Dir | S - Sale | $29.14 | -7,867 | 21,158 | -27% | -$229,226 | ||||||
| M | 2025-01-06 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $29.66 | -7,689 | 384,459 | -2% | -$228,067 | |||||
2025-01-06 | CSTL | Castle Biosciences Inc | Juvenal Tobin W | Chief Commercial Officer | S - Sale | $30.00 | -2,230 | 72,173 | -3% | -$66,900 | ||||||
2025-01-07 | LH | Labcorp Holdings Inc. | Anderson Kerrii B | Dir | S - Sale | $235.00 | -1,000 | 13,010 | -7% | -$235,000 | ||||||
2025-01-06 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $7.69 | -100 | 6,536 | -2% | -$769 | ||||||
| D | 2025-01-02 | VCYT | Veracyte, Inc. | Eastham Karin | Dir | S - Sale+OE | $40.30 | -10,000 | 18,497 | -35% | -$403,006 | |||||
2025-01-02 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $159.50 | -5,700 | 343,936 | -2% | -$909,126 | ||||||
2024-12-23 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $159.60 | -669 | 114,142 | -1% | -$106,773 | ||||||
2024-12-23 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $159.60 | -2,428 | 116,997 | -2% | -$387,511 | ||||||
2024-12-18 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $167.25 | -5,700 | 396,414 | -1% | -$953,337 | ||||||
2024-12-18 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $34.85 | -116 | 2,810 | -4% | -$4,043 | ||||||
2024-12-17 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $28.34 | -9,364 | 392,148 | -2% | -$265,358 | ||||||
2024-12-16 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $3.82 | -4,834 | 123,886 | -4% | -$18,466 | ||||||
2024-12-16 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $3.82 | -1,513 | 65,875 | -2% | -$5,780 | ||||||
2024-12-16 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $3.82 | -6,865 | 167,098 | -4% | -$26,224 | ||||||
| M | 2024-12-13 | PMD | Psychemedics Corp | Powell Anderson Capital Partners LLC | 10% | P - Purchase | $1.91 | +159,700 | 614,406 | +35% | +$305,439 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |